BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38338893)

  • 1. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.
    Zanrè V; Bellinato F; Cardile A; Passarini C; Monticelli J; Di Bella S; Menegazzi M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Insight on Activation of Human Endogenous Retroviruses (HERVs) in Malignant Melanoma upon Exposure to CuSO4.
    Karimi A; Sheervalilou R; Kahroba H
    Biol Trace Elem Res; 2019 Sep; 191(1):70-74. PubMed ID: 30539386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human endogenous retroviruses and cancer prevention: evidence and prospects.
    Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
    BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin Elicits Cytostatic/Cytotoxic Activity in Human Melanoma Cell Lines, Inhibiting Pro-Survival NF-κB, STAT3, AP1 Transcription Factors and the Expression of Functional Proteins Involved in Mitochondrial and Cytosolic Metabolism.
    Cardile A; Zanrè V; Campagnari R; Asson F; Addo SS; Orlandi E; Menegazzi M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human endogenous retrovirus-K by antiretroviral drugs.
    Tyagi R; Li W; Parades D; Bianchet MA; Nath A
    Retrovirology; 2017 Mar; 14(1):21. PubMed ID: 28330477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.
    Botti G; Fratangelo F; Cerrone M; Liguori G; Cantile M; Anniciello AM; Scala S; D'Alterio C; Trimarco C; Ianaro A; Cirino G; Caracò C; Colombino M; Palmieri G; Pepe S; Ascierto PA; Sabbatino F; Scognamiglio G
    J Transl Med; 2017 Feb; 15(1):46. PubMed ID: 28231855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation.
    Reiche J; Pauli G; Ellerbrok H
    Melanoma Res; 2010 Oct; 20(5):435-40. PubMed ID: 20539243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.
    Yee KL; DiBenedetto A; Fan L; Khalilieh S; Triantafyllou I; Vallee MH; Fackler P; Stoch SA; Iwamoto M
    AAPS PharmSciTech; 2020 Feb; 21(3):91. PubMed ID: 32060665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
    Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
    Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
    Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity.
    Subhadarshini S; Sahoo S; Debnath S; Somarelli JA; Jolly MK
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37678920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
    Gambichler T; Harnischfeger F; Skrygan M; Majchrzak-Stiller B; Buchholz M; Müller T; Braumann C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.
    Sciarretta F; Fulci C; Palumbo C; Rotili D; Tentori L; Graziani G; Caccuri AM
    Chemotherapy; 2019; 64(3):138-145. PubMed ID: 31639786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma.
    Schmitt K; Reichrath J; Roesch A; Meese E; Mayer J
    Genome Biol Evol; 2013; 5(2):307-28. PubMed ID: 23338945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma.
    Schanab O; Humer J; Gleiss A; Mikula M; Sturlan S; Grunt S; Okamoto I; Muster T; Pehamberger H; Waltenberger A
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):656-65. PubMed ID: 21501418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the
    Jeffrey JL; St Clair M; Wang P; Wang C; Li Z; Beloor J; Talarico C; Fridell R; Krystal M; White CT; Griffith S; D'Amico R; Smith K; Van Eygen V; Vingerhoets J; Vandermeulen K; Spreen W; van Lunzen J
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0170221. PubMed ID: 34978890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells.
    Lee JJ; Kim SY; Kim SH; Choi S; Lee B; Shin JS
    Cell Death Dis; 2022 Sep; 13(9):791. PubMed ID: 36109513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Margolis DA; Gonzalez-Garcia J; Stellbrink HJ; Eron JJ; Yazdanpanah Y; Podzamczer D; Lutz T; Angel JB; Richmond GJ; Clotet B; Gutierrez F; Sloan L; Clair MS; Murray M; Ford SL; Mrus J; Patel P; Crauwels H; Griffith SK; Sutton KC; Dorey D; Smith KY; Williams PE; Spreen WR
    Lancet; 2017 Sep; 390(10101):1499-1510. PubMed ID: 28750935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
    Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
    J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.